In October 2025, Boston Scientific unveiled its new 400,000-square-foot campus in Maple Grove, Minnesota, marking a significant milestone in the company’s expansion efforts. The $170 million facility, situated on a 40-acre site near Arbor Lakes and Interstate 694, serves as the divisional headquarters for Boston Scientific’s cardiovascular business, which includes products like stents and pacemakers. The campus features state-of-the-art research and development labs, an innovation center, and collaborative workspaces designed to foster innovation and collaboration among engineers, physicians, and visiting cardiologists.
The decision to establish the new campus in Maple Grove was strategic. The city, already home to approximately 4,000 Boston Scientific employees, was chosen over other potential locations in Massachusetts and Georgia. The expansion is expected to create over 1,500 jobs, ranging from scientists and engineers to administrative and support staff, further solidifying Maple Grove’s role as a hub for medical technology innovation.
Healthcare data growth can be overwhelming scale effortlessly with TrueNAS by Esdebe.
The facility’s design emphasizes sustainability and employee well-being. It includes a conference center, fitness suite, and cafeteria, promoting a healthy and collaborative work environment. Additionally, the building incorporates environmentally friendly features such as photovoltaic arrays, geothermal energy technologies, and a stormwater filtration system, reflecting Boston Scientific’s commitment to environmental responsibility.
This expansion is part of Boston Scientific’s broader strategy to enhance its research and development capabilities and strengthen its presence in the medical technology sector. The new campus is expected to support ongoing growth in the company’s cardiovascular and electrophysiology divisions, enabling greater focus on R&D and product testing while transitioning more manufacturing operations to its existing Weaver Lake site.
The opening of the Maple Grove campus also highlights the economic impact of Boston Scientific’s operations in Minnesota. The project received financial support from the state, including funds from the Job Creation Fund and the Minnesota Investment Fund, facilitating the development and job creation associated with the expansion. Local leaders have praised the project, emphasizing its significance for the community and the state’s economy.
In summary, Boston Scientific’s new Maple Grove campus represents a substantial investment in Minnesota’s medical technology sector, bringing advanced research facilities, job opportunities, and economic growth to the region. The expansion underscores the company’s commitment to innovation and its strategic focus on enhancing its capabilities in the cardiovascular and electrophysiology fields.
Be the first to comment